Amenorrhea and Menopause in Patients with Breast Cancer after Chemotherapy.
Conclusion: Marked discrepancy in the rates of CIM and TRA was observed in this study. Further, the age-specific frequency of CIM and TRA observed in this study is a reliable and practical estimate of the risks of CIM and TRA in the absence of gonadal protection.
PMID: 31897335 [PubMed]
Source: Journal of Breast Cancer - Category: Cancer & Oncology Tags: J Breast Cancer Source Type: research
More News: Amenorrhea | Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Docetaxel | Men | Menopause | Ovarian Cancer | Ovaries | Study | Tamoxifen | Taxotere | Women